You are here: Industry Insights > Catalent

News List

Woodstock Sterile Solutions Names Oliver Vogt as VP and General Manager contractpharma
May 12, 2021
Woodstock Sterile Solutions, a blow-fill-seal (BFS) contract development and manufacturing organization (CDMO), has appointed Oliver Vogt as its vice president and general manager – Site Operations.
Catalent Acquires Commercial-Scale Plasmid DNA Mfg. Facility contractpharma
May 08, 2021
Promethera’s Hepatic Cell Therapy Support SA include's 32,400 sq.-ft. facility in Gosselies, Belgium.
Catalent and Stirling Ultracold Enter Cold Chain Partnership contractpharma
April 30, 2021
Catalent, a global provider of advanced delivery technologies, development, manufacturing, and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Stirling Ultracold, an innovative developer and ...
AavantiBio, Catalent Enter Gene Therapy Alliance contractpharma
April 29, 2021
AavantiBio, a gene therapy company focused on rare genetic diseases, and Catalent entered a partnership to support the development and manufacturing of AavantiBio’s gene therapies, including its lead program in Friedreich’s Ataxia (FA).
Catalent Adds Cryogenic Capabilities at Philadelphia Facility contractpharma
April 16, 2021
Bolsters clinical supply services at site to meet growing demand for cell and gene therapy development.
Catalent Biologics Completes Madison Expansion contractpharma
April 14, 2021
Catalent has completed the expansion of two new suites at its biologics drug substance development and manufacturing facility in Madison, WI, and began work on customer programs.
Moderna, Catalent Enter Long-Term Strategic Vax Pact contractpharma
April 08, 2021
Catalent to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs.
SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions contractpharma
April 01, 2021
SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, has completed its previously announced acquisition of the Blow-Fill-Seal (BFS) Sterile Contract Development and Manufacturing ...
Cybin to Leverage Catalent’s Zydis for Psychiatric Drug contractpharma
March 23, 2021
To apply Zydis orally disintegrating tablet (ODT) technology for delivery of Cybin’s potential therapy for treatment-resistant psychiatric disorders.
Catalent Expands Partnership with J&J contractpharma
March 18, 2021
Catalent Pharma Solutions has expanded its partnership with Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc., two of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page